Matthew Riley | executive |
Alfred Altomari | executive |
Good morning, and welcome to the Agile Therapeutics Fourth Quarter and Full Year 2023 Financial Results Conference Call. Please note, today's event is being recorded. I would now like to turn the conference over to Matt Riley, Head of Investor Relations. Please go ahead.
Hello, everyone, and welcome to today's conference call to discuss our fourth quarter and full year 2023 financial results and corporate update.